Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Structural Heart Devices Market to Reach USD 12.93 Billion by 2032 Driven by Rapid Adoption of TAVR and Minimally Invasive Transcatheter Therapies - Credence Research

prnewswire.com
ABT Abbott is identified as a major player in the structural heart devices market, which is projected for significant growth. The company's focus on transcatheter platforms and expanded indications aligns with positive market trends. MDT Medtronic is listed as a major player in the growing structural heart devices market. Their investment in transcatheter platforms and expanded indications positions them to benefit from market expansion and innovation. BSX Boston Scientific is recognized as a key competitor in the expanding structural heart devices market. Their focus on transcatheter platforms and indications suggests they are well-positioned for growth. EW Edwards Lifesciences is highlighted as a major player in the structural heart devices market, which is expected to grow substantially. Their continued investment in transcatheter platforms supports a positive outlook. ATRC AtriCure is mentioned as a player in the structural heart devices market, which is anticipated to grow significantly. Their involvement suggests potential to benefit from market expansion and innovation in minimally invasive therapies.

Structural Heart Devices Market to Reach USD 12.93 Billion by 2032 Driven by Rapid Adoption of TAVR and Minimally Invasive Transcatheter Therapies - Credence Research LONDON, March 4, 2026 /PRNewswire/ -- The " Structural Heart Devices Market – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032" report has been added to the Credence Research Inc. offering.

The global Structural Heart Devices Market was valued at USD 5.21 billion in 2018, reached USD 6.68 billion in 2024, and is anticipated to reach USD 12.93 billion by 2032, registering a CAGR of 8.65% during the forecast period. The market's growth reflects rising structural heart disease prevalence, expanding clinical indications for transcatheter therapies, and strong physician and patient preference for minimally invasive procedures that improve recovery outcomes.

Key Takeaways:

Scope & Segmentation – Structural Heart Devices Market

The report provides a comprehensive analysis of the global Structural Heart Devices Market, covering revenue forecasts from 2024 to 2032. It evaluates market drivers, trends, challenges, competitive landscape, and regional dynamics across transcatheter and surgical device categories. The study assesses innovation in transcatheter valve replacement and repair, expanding regulatory approvals, clinical evidence development, and the role of advanced imaging and navigation technologies in improving procedural safety and effectiveness.

The structural heart devices market is segmented based on product, procedure, end-use, and geography.

Request your sample report today & start making informed decisions powered by Credence Research Inc.! - https://www.credenceresearch.com/report/structural-heart-devices-market

Why This Report Matters

Market Overview:

Market Insights:

Key Attributes

Attribute

Details

Market Size 2018

USD 5.21 Billion

Market Size 2024

USD 6.68 Billion (USD 6,683.01 Million)

Market Size 2032

USD 12.93 Billion (USD 12,931.90 Million)

CAGR (2025–2032)

8.65 %

Forecast Period

2025–2032

Base Year

2024

Segmentation Covered

Product, Procedure, End-use, Geography

Key Regions

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Major Players

Abbott, Medtronic, Boston Scientific, Edwards Lifesciences, LivaNova, AtriCure, BIOMERICS, JenaValve, LEPU Medical, CryoLife, NUMED

Regional Growth Reflects Procedure Adoption and Healthcare Capacity

Market Challenges Include High Costs, Regulatory Complexity, and Procedural Risk

Despite strong growth prospects, the market faces constraints from the high cost of devices and procedures, particularly transcatheter interventions that require expensive implants, specialized equipment, and skilled operators. Cost sensitivity and reimbursement limitations may restrict adoption in developing markets.

The market also faces stringent and time-intensive regulatory pathways, requiring robust clinical evidence, long trial cycles, and significant R&D investment. Approval delays can slow market entry and limit near-term expansion.

In addition, procedural and device-related complications including leakage, incorrect placement, and device malfunction remain concerns. Continued design improvements and standardized operator training are essential to expand adoption and sustain long-term growth.

Future Outlook

The Structural Heart Devices Market is poised for sustained growth through 2032, supported by the continued expansion of transcatheter procedures, broader clinical indications, and rapid technology innovation in valves, closure devices, and delivery systems.

Integration of imaging and navigation tools will continue improving accuracy and outcomes, while emerging markets will play a larger role as healthcare systems expand access to advanced cardiac interventions. As clinical adoption spreads beyond high-risk cohorts, structural heart therapies will remain central to the evolution of minimally invasive cardiovascular care.

Competitive Landscape

The structural heart devices market remains highly competitive, with leading companies focusing on product innovation, strategic partnerships, acquisitions, and geographic expansion. Major players including Abbott, Medtronic, Boston Scientific, Edwards Lifesciences, and LivaNova continue to invest in transcatheter platforms and expanded indications, while other companies strengthen niche capabilities and regional penetration across fast-growing markets.

Key Player Analysis

Recent Industry Developments

Download Sample - https://www.credenceresearch.com/report/structural-heart-devices-market

Related Reports –

Congestive Heart Failure Treatment Devices Market https://www.credenceresearch.com/report/congestive-heart-failure-treatment-devices-market

Prosthetic Heart Valves Market https://www.credenceresearch.com/report/prosthetic-heart-valves-market

Transcatheter Heart Valve Replacement Market https://www.credenceresearch.com/report/transcatheter-heart-valve-replacement-market

Structural Heart Devices Market https://www.credenceresearch.com/report/structural-heart-devices-market

Cardiac Surgery and Heart Valve Devices Market https://www.credenceresearch.com/report/cardiac-surgery-and-heart-valve-devices-market

At-Home Heart Health Testing Market https://www.credenceresearch.com/report/at-home-heart-health-testing-market

Flea Tick and Heartworm Products Market https://www.credenceresearch.com/report/flea-tick-and-heartworm-products-market

Heart Valve Devices Market https://www.credenceresearch.com/report/heart-valve-devices-market

Heart Failure Drugs Market https://www.credenceresearch.com/report/heart-failure-drugs-market

Heart Rate Monitor Market https://www.credenceresearch.com/report/heart-rate-monitor-market

About Us

Credence Research Inc is a global market intelligence and consulting firm founded in 2015. It delivers deep market insights, quantitative analysis, and strategic guidance to business leaders, investors, governments, NGOs, and non-profit groups worldwide. The company helps organizations evaluate markets, understand trends, reduce risk, and make data-driven decisions that support growth and competitive strategy. Credence Research is known for rigorous research methods and comprehensive analytics.

The firm produces detailed reports covering market size, forecasts, growth drivers, trends, and competitive landscapes across many industries. Each report often includes frameworks like PESTLE and Porter's Five Forces to give a complete view of market dynamics and future potential. Credence Research also provides tailored consulting services, due diligence support, go-to-market planning, and pre-IPO research to strengthen client strategies and investment narratives. Its insights come from both primary and secondary research, expert interviews, and advanced data modelling. The firm's client base spans Europe, the Americas, Asia-Pacific, and the Middle East/Africa.

To find out more, visit www.credenceresearch.com or follow us on X.com, LinkedIn and Facebook

Contact Us –

Credence Research Inc,

Tower C-1105, S 25,

Akash Tower,

Vishal Nagar,

Pimple Nilakh, Haveli,

Pune – 411027, India

USA: +1-888-600-6441

Email: [email protected]

Visit Our Website: https://www.credenceresearch.com/

Logo - https://mma.prnewswire.com/media/2562161/Credence_Research_Logo.jpg

SOURCE Credence Research Inc.